EA199700242A1 - Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нтрецептора - Google Patents

Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нтрецептора

Info

Publication number
EA199700242A1
EA199700242A1 EA199700242A EA199700242A EA199700242A1 EA 199700242 A1 EA199700242 A1 EA 199700242A1 EA 199700242 A EA199700242 A EA 199700242A EA 199700242 A EA199700242 A EA 199700242A EA 199700242 A1 EA199700242 A1 EA 199700242A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmocomposition
ntreceptor
indasolkarboxamida
inhibiting
recovery
Prior art date
Application number
EA199700242A
Other languages
English (en)
Other versions
EA000699B1 (ru
Inventor
Джон Т. Кэтлоу
Марлен Л. Кохен
Майкл Дж. Мартинелли
Джон М. Скаус
Стивен П. Свансон
Деннис С. Томпсон
Томас М. Уилсон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/485,956 external-priority patent/US5654320A/en
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199700242A1 publication Critical patent/EA199700242A1/ru
Publication of EA000699B1 publication Critical patent/EA000699B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Предложены индазолкарбоксамиды для применения в качестве антагонистов и частичных агонистов серотонинового рецептора 5-HT, а также терапевтические способы лечения заболеваний, вызванных нарушением или подверженных влиянию нарушения функции рецептора 5-HT, с использованием таких соединений.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199700242A 1995-03-16 1996-03-14 Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нт4 рецептора EA000699B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40511995A 1995-03-16 1995-03-16
US08/485,956 US5654320A (en) 1995-03-16 1995-06-07 Indazolecarboxamides
PCT/US1996/003551 WO1996033713A1 (en) 1995-03-16 1996-03-14 Indazolecarboxamides

Publications (2)

Publication Number Publication Date
EA199700242A1 true EA199700242A1 (ru) 1998-04-30
EA000699B1 EA000699B1 (ru) 2000-02-28

Family

ID=27018928

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199700242A EA000699B1 (ru) 1995-03-16 1996-03-14 Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нт4 рецептора

Country Status (23)

Country Link
US (2) US5798367A (ru)
EP (1) EP0732333B1 (ru)
JP (1) JPH11502230A (ru)
CN (1) CN1112923C (ru)
AT (1) ATE203748T1 (ru)
AU (1) AU700842B2 (ru)
BR (1) BR9608223A (ru)
CA (1) CA2215359A1 (ru)
DE (1) DE69614164T2 (ru)
DK (1) DK0732333T3 (ru)
EA (1) EA000699B1 (ru)
ES (1) ES2159345T3 (ru)
GR (1) GR3037029T3 (ru)
HU (1) HU223973B1 (ru)
IL (1) IL117438A (ru)
NO (1) NO312833B1 (ru)
NZ (1) NZ315971A (ru)
PL (1) PL183867B1 (ru)
PT (1) PT732333E (ru)
RO (1) RO119617B1 (ru)
SK (1) SK283924B6 (ru)
TR (1) TR199700956T1 (ru)
WO (1) WO1996033713A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US5914405A (en) * 1997-10-07 1999-06-22 Eli Lilly And Company Process for preparing 3-substituted indazoles
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
EE05054B1 (et) * 1998-08-21 2008-08-15 Novartis Ag 5-HT4 agonisti v?i antagonisti peroraalne ravimkoostis ja selle kasutamine meditsiinis
CA2340952C (en) 1998-09-10 2009-12-08 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
WO2002004411A1 (en) 2000-07-07 2002-01-17 The Administrators Of The Tulane Educational Fund Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
US20050032866A1 (en) * 2000-08-07 2005-02-10 Bonhomme Mireille Marguerite Jeanne The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
AU2003208711A1 (en) 2002-02-12 2003-09-04 Akzo Nobel N.V. 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20031467A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco attivo nel dolore neuropatico
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
SE0401969D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Piperidine derivatives
DE602006010563D1 (de) 2005-07-22 2009-12-31 Pfizer Indazolcarbonsäureamidderivate als agonisten des 5ht4-rezeptors
WO2009106980A2 (en) * 2008-02-29 2009-09-03 Pfizer Inc. Indazole derivatives
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145215A (en) * 1961-12-19 1964-08-18 Sterling Drug Inc Indazole derivatives
JP2795460B2 (ja) * 1988-06-20 1998-09-10 協和醗酵工業株式会社 ピラゾロアクリドン誘導体
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
EP0410509A1 (en) * 1989-07-25 1991-01-30 Duphar International Research B.V New substituted 1H-indazole-3-carboxamides
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
US5552398A (en) * 1991-09-12 1996-09-03 Smithkline Beecham P.L.C. Azabicyclic compounds as 5-HT4 receptor antagonists
AU4081393A (en) * 1992-05-23 1993-12-30 Smithkline Beecham Plc Medicaments for the treatment of anxiety
WO1994000113A2 (en) * 1992-06-27 1994-01-06 Smithkline Beecham Plc Medicaments containing 5-ht4 receptor antagonists
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
TW251287B (ru) * 1993-04-30 1995-07-11 Nissei Co Ltd
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
PL183867B1 (pl) 2002-07-31
GR3037029T3 (en) 2002-01-31
NZ315971A (en) 1999-01-28
EP0732333A1 (en) 1996-09-18
NO974221D0 (no) 1997-09-12
CN1112923C (zh) 2003-07-02
IL117438A0 (en) 1996-07-23
EP0732333B1 (en) 2001-08-01
ATE203748T1 (de) 2001-08-15
HUP9801386A3 (en) 2000-03-28
DK0732333T3 (da) 2001-10-08
RO119617B1 (ro) 2005-01-28
AU700842B2 (en) 1999-01-14
HU223973B1 (hu) 2005-03-29
TR199700956T1 (xx) 1998-02-21
US5817676A (en) 1998-10-06
DE69614164D1 (de) 2001-09-06
EA000699B1 (ru) 2000-02-28
MX9706967A (es) 1997-11-29
HUP9801386A2 (hu) 1999-06-28
IL117438A (en) 2001-12-23
PT732333E (pt) 2001-11-30
DE69614164T2 (de) 2002-04-25
SK283924B6 (sk) 2004-05-04
NO312833B1 (no) 2002-07-08
CN1183041A (zh) 1998-05-27
NO974221L (no) 1997-10-27
BR9608223A (pt) 1998-12-29
CA2215359A1 (en) 1996-10-31
AU6894896A (en) 1996-11-18
ES2159345T3 (es) 2001-10-01
US5798367A (en) 1998-08-25
SK124297A3 (en) 1998-02-04
PL322362A1 (en) 1998-01-19
WO1996033713A1 (en) 1996-10-31
JPH11502230A (ja) 1999-02-23

Similar Documents

Publication Publication Date Title
EA199700242A1 (ru) Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нтрецептора
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
EA199700117A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов
RU93058531A (ru) Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ лечения
ATE466014T1 (de) Spiroazacyclische verbindungen als monoaminrezeptormodulatoren
MXPA00010060A (es) Receptores de serotonina humana constitutivamente activados, no endogenos y moduladores de molecula pequenos de los mismos.
EA200200647A1 (ru) АГОНИСТЫ β2-АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
DK0804236T3 (da) Anvendelse af anti-TNF-antistoffer som lægemidler til behandling af sygdomme, som involverer forhøjede interleukin-6-serumniveauer
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
ATE318845T1 (de) Therapeutische multispezifische verbindungen, die antikörper gegen den fcalpha-rezeptor enthalten
EA199700116A1 (ru) Трициклические бензазепины как антагонисты вазопрессина, способ их получения, фармкомпозиция на их основе и способ лечения
FI964004A0 (fi) Serotoniiniantagonistien (5HT3) käyttö fibromyalgian hoitoon
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
EA200300183A1 (ru) Новое сочетание агониста (5-th2) и антагониста (5-ht6) серотонина в качестве фармацевтической композиции
UA66865C2 (ru) Инденопирролокарбазолы, фармацевтическая композиция, способ ингибирования киназной активности и способ лечения (варианты)
NO944578L (no) Eksitatoriske aminosyre reseptor antagonister
EA199700111A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина
DE69931957D1 (de) Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns-erkrankungen
EA199900206A1 (ru) Способ лечения обычной простуды или аллергического ринита
DE3650647D1 (de) Arzneimittel zur Behandlung von Anxietas
ES2169257T3 (es) Nuevas isoquinolinas fusionadas como ligandos del receptor de la dopamina.
ATE434437T1 (de) Verwendung von antagonisten der 5-ht3-rezeptoren zur behandlung von muskuloeskeletalen erkrankungen
EA200000322A1 (ru) Способ синтеза производных хинолина
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
EA200000693A1 (ru) Антагонисты хемокинного рецептора и способы их применения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU